HealthSouth Corporation Reports Q2 EPS of $1.66; Revenue of $564.50M vs $553.41M Est; Sees FY13 EBITDA $520-530M

By: Benzinga
HealthSouth Corporation (NYSE: HLS ) reports Q2 EPS of $1.66. Revenue came in at $564.50M versus the estimated $553.41M. Sales were Up 6% year over year. (c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.